key: cord-0819627-7g5fu69c
authors: van der Zalm, Marieke M; Lishman, Juanita; Verhagen, Lilly M; Redfern, Andrew; Smit, Liezl; Barday, Mikhail; Ruttens, Dries; da Costa, A’ishah; van Jaarsveld, Sandra; Itana, Justina; Schrueder, Neshaad; Van Schalkwyk, Marije; Parker, Noor; Appel, Ilse; Fourie, Barend; Claassen, Mathilda; Workman, Jessica J; Goussard, Pierre; Van Zyl, Gert; Rabie, Helena
title: Clinical experience with SARS CoV-2 related illness in children - hospital experience in Cape Town, South Africa
date: 2020-11-10
journal: Clin Infect Dis
DOI: 10.1093/cid/ciaa1666
sha: d4cdf57d0b5544915e431794c6a116ba7a9c07e6
doc_id: 819627
cord_uid: 7g5fu69c

BACKGROUND: Children seem relatively protected from serious severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) related disease, but little is known about children living in settings with high tuberculosis and HIV burden. This study reflects clinical data on South African children with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). METHODS: We collected clinical data of children aged younger than 13 years with laboratory confirmed SARS-CoV-2 presenting to Tygerberg Hospital, Cape Town between 17th of April and 24th of July 2020. RESULTS: Hundred and fifty-nine children (median age 48·0 months (interquartile range, IQR 12·0-106·0)) were included. Hospitalized children (n=62), median age of 13·5 months (IQR 1·8-43·5) were younger than children not admitted (n=97), median age 81·0 months (IQR 34·5-120·5, p< 0·01). Thirty-three of 159 (20·8%) children had pre-existing medical conditions. Fifty-one of 62 (82·3%) hospitalized children were symptomatic; lower respiratory tract infection was diagnosed in 21/51 (41·2%) and 11/16 (68·8%) children younger than 3 months of age. Respiratory support was required in 25/51 (49·0%) children; 13/25 (52·0%) children were younger than 3 months. One child was HIV infected and 11/51 (21·2%) were HIV exposed uninfected and 7/51 (13·7%) children had a recent or new diagnosis of tuberculosis. CONCLUSION: Children less than 1 year of age hospitalized with SARS-CoV-2 in Cape Town frequently required respiratory support, the access to oxygen may be limited in some LMICs which could potentially drive morbidity and mortality. HIV infection was uncommon but a relationship between HIV exposure, tuberculosis and SARS-CoV-2 should be explored.

Accumulating data shows that children and adolescents are relatively protected from severe COVID- 19 , and the majority are asymptomatic or have mild disease. 1, 2 When severe disease does occur in young children and adolescents the case fatality rates remain low. To date, data on COVID-19 in children in low-middle income countries (LMICs) and Sub-Saharan Africa in particular are sparse and results from China, Europe and North America may not be directly applicable. [1] [2] [3] [4] Compared to well-resourced settings, the under-5 pneumonia mortality rate is significantly higher in Sub-Saharan Africa. 5 The reasons for this includes a high prevalence of tuberculosis, HIV, other infectious diseases and other poverty related illnesses, in particular malnutrition. 6,7 Risk factors associated with poor outcomes in pneumonia could potentially have an important impact on COVID-19 outcomes. Crowding and poor housing may increase the disease burden and delayed access to care for the underprivileged population may lead to higher morbidity and mortality. COVID-19 may therefore impact children in Sub-Saharan Africa diferently. 8 South Africa is the epicentre of the COVID-19 pandemic in Sub-Saharan Africa over the last months, with Cape Town as the initial epicenter. 9,10 Of the first 116 adult patients with COVID-19 illness admitted to a hospital in Cape Town, 24 (21%) were HIV infected, four patients had tuberculosis at admission, and nine had history of prior tuberculosis. 11 In 2018 there were ~450,000 people living with HIV in the Western Cape, including about 13,000 children <15 years of age. In that same year there were an estimated 56,000 new tuberculosis cases, with around 40% of tuberculosis cases also co-infected with HIV. 12 Comparable analysis for children living in a setting with a high burden of tuberculosis and HIV is not available. We hypothesize that COVID-19 illness in children living in a A c c e p t e d M a n u s c r i p t 6 setting with a high burden of tuberculosis and HIV might be more severe due to high prevalence of underlying infectious diseases and poor nutrition. This study reflects the clinical experience at the pediatric department of a major hospital in Cape Town, South Africa.

We present routine care data from an observational cohort of children aged 0-13 years with a laboratory confirmed diagnosis of SARS-CoV-2 presenting to Tygerberg Hospital (TBH). We defined laboratory confirmation as a positive test for SARS-CoV-2 on real-time reverse-transcription polymerase chain reaction (rRT-PCR) on a respiratory sample. We excluded infants born diagnosed in the neonatal service and children diagnosed with Multi System Inflammatory Syndrome (MIS-C) who did not have a positive rRT-PCR. We included data from the 17 th of April till 24 th of July 2020. At TBH the first confirmed positive SARS-CoV-2 rRT-PCR in a child was on 17 April 2020. 13

Setting TBH is a hospital in Cape Town providing secondary and tertiary care. As infections increased and community spread accelerated, the case definitions and indication for testing were adjusted according to the local prevalence and testing capacity (see online supplement, Figure 1 ). Pulse oximetry oxygen measurement of less than 94% or less is used as a cut-off for oxygen supplementation. At TBH children receive non-invasive respiratory support (NIRS) via heated humidified high flow nasal cannula oxygen (HFNO) via the Optiflow© system or nasal continuous positive airway pressure (CPAP) via variable flow Fischer-Paykel© simple CPAP system in designated pediatric ward high care areas, as intensive care spaces are limited. N95 respirators, visor, disposable gown and gloves were used when managing these patients.

A c c e p t e d M a n u s c r i p t 7

Total nucleic acid content was isolated using the NUCLISENS® EASYMAG® system (bioMérieux, Marcy l'Etoile, France) and NIMBUS automated extraction systems (Seegene, Seoul, Republic of Korea). SARS-CoV-2 RT-PCR testing was performed with the Allplex™ 2019-nCoV assay (Seegene, Seoul, Republic of Korea) at the Division Medical Virology, Stellenbosch University and National Health Laboratory Service Tygerberg. This assay detects 3 genes (E-Gene, RdRP-gene and the N-Gene) and an internal control in a multiplex PCR reaction. During short periods of reagent shortage an inhouse-SARS-CoV-2 PCR using the primers described by Corman and colleagues. 14 Manufacturers cycle threshold (Ct) cut-off values for positive tests were used.

Children with positive SARS-COV-2 test were identified from the hospital record keeping systems.

We collected data from the routine screening documentation used at the testing areas as per National Department of Health (NDOH), the paper based clinical records and electronic clinical records as well as from the laboratory data system for hospitalized children. Images where reviewed on the picture archiving and communication system and chest radiographs (CXR) were evaluated by a pediatric pulmonologist.

Weight-for-age z-scores (WAZ) were calculated using the WHO child growth standards for children up to 10 years. For children older than 10 weight-for-age percentiles where determined with the CDC calculator. Chi-squared test was used to compare the differences between in and outpatients and the different age groups. The Yates continuity correction was used if the expected cell size was less than 5. Nonparametric tests were used to compare differences between the age groups and continuous/ dichotomous variables (Kruskal-Wallis test/ Mann-Whitney U test).

The Human Research Ethics Committee (HREC N20/04/013_COVID) of the Faculty of Health Sciences, Stellenbosch University, South Africa approved this study. The data was entered without patient identifiers using only routinely collected data. A waiver of consent for this process was obtained.

Between April 17 th and July 24 st 2020, 1126 SARS-CoV-2 PCR tests were performed on children aged 0-13, among whom 159 (14·1%) tested positive for SARS-CoV-2. A slight male predominance was noted in both children needing hospitalization (n=35; 56·5%) and children that were not admitted (n=53; 54·6%) ( Table 1 ). The median age of all children was 48·0 months (interquartile range IQR 12·0-106·0), hospitalized children were significantly younger with a median age of 13·5 months (IQR 1·8-43·5) compared to children who were not admitted with a median age of 81·0 months (IQR 34·5-120·5, p< 0·01). Forty-one of 159 (25·8%) children were less than one year of age including 30/62 (48·4%) of the admitted children.

A c c e p t e d M a n u s c r i p t 9 Pre-existing medical conditions were noted in 33/159 (20·8%) children; 4/97 (4·1%) of the outpatients and 29/62 (46·8%) of the admitted children. A total of 5/62 (8·1%) of the children had hematology-oncological conditions (1 sickle cell, 1 aplastic anemia), 11/62 (29·7%) of children were known to be HIV-exposed but not infected and 8/62 (5·0%) were known to be premature. Two of the 62 (3·6%) hospitalized children were HIV-infected, 2/62 (1·9%) children were recently diagnosed with pulmonary tuberculosis and on treatment at the time of SARS-CoV-2 testing, 1 had recent history of tuberculosis meningitis. Asthma and sickle cell anemia each were noted in one child each.

Children that did not require admission presented with cough and sore throat more frequently compared to hospitalized children (59·8% vs 35·5%, p= 0.04 and 22·2% vs 12·5% , p=0.03 respectively). Gastro-intestinal symptoms like diarrhea and vomiting were more frequently reported in the hospitalized children compared to the non-admitted children (19·4% vs 10·3%, p= 0.03 and 24·1% vs 2·1% , p<0.01 respectively).

Weight-for-height and BMI were not available, but as per weight-for-age the hospitalized children were not malnourished or overweight; for children younger than 10 years the median WAZ was -0·5

(IQR -1·6-0·3) ( Table 2 ). The weight-for-age percentiles in the older children ranged from 59 th to 76 th percentile.

Ten of the 62 (16·1%) hospitalized children were asymptomatic and tested for SARS-CoV-2 for other reasons, these children were removed from the clinical analysis (Table 2 ). Males were predominant in all age groups, but specifically in children younger than 3 months of age. Admission diagnosis A c c e p t e d M a n u s c r i p t 10 made by treating physician and lower respiratory tract infection (LRTI) was the most common COVID-19 related reason for hospitalization, in 21/51 (41·2%) children. Children less than 12 months, and particularly less than 3 months were most likely to be admitted with LRTI. Gastro-intestinal symptoms were the most common clinical presentation in children older than 5 years of age, including abdominal pain, diarrhea and vomiting. Six hospitalized children presented with seizures, which were focal in nature in three children. Lumbar punctures were done in all these children and did not suggest meningitis. One child presented with a stroke (right middle cerebral artery), and SARS-CoV-2 PCR was negative on the cerebrospinal fluid of this child. As previously reported 15 , four children with a positive SARS-CoV-2 test were initially diagnosed with acute appendicitis, three had appendectomy and where diagnosed with MIS-C and in the fourth child MIS-C was excluded clinically. Six of the admitted children had a rash at presentation; 1 child was suspected of measles however antibody tests were negative in this child. One child had a rash compatible with MIS-C clinical picture.

Laboratory markers showed that CRP and platelet counts were only slightly elevated (Online supplement, Table 1 ). CRP was significantly higher in the oldest age group compared to the youngest children (p= 0.04) Of 40 children with CXR, 38 (95·0%) had an acceptable quality CXR (Online supplement Table 1 ). Of these, 7 (18·4%) had normal CXRs, 16 (42·1%) had diffuse alveolar disease, 6 (15·7%) had perihilar infiltrate, 3 (7·9%) had a lobar pneumonia and 3 (7·9%) had a bronchopneumonia. Twelve out of 21 (57·1%) children with LRTI, had diffuse alveolar disease on CXR. The proportion of children with LRTI and alveolar disease on CXR was highest in children younger than 3 months of age (8/11, 72.7%).

A c c e p t e d M a n u s c r i p t 11 Oxygen supplementation was required in 25/ 51 (49·0%) children, of whom 14/51 (27·5%) children required NIRS (HFNO or CPAP) in the wards or in the PICU. Both the need for respiratory support as well as the duration of support was highest in children younger than 3 months of age; in this group 13 out of 16 (81·3%) children required respiratory support. The duration of respiratory support was not significantly different between groups.

Intensive care admission was common, 11 of the 51 (21·6%) children with median age 20 months (IQR 3·0-62·0) needed PICU admission (Table 3) . Pneumonia was the indication for admission in five children, of whom 4 required intubation. There were no deaths among those admitted to the PICU.

The median hospital length of stay was 5 days (IQR 2·0-9·0). One child died, a 5-week old infant that was HIV exposed but uninfected (HEU). He initially presented with only fever and presumed bacterial sepsis and was treated with antibiotics. The SARS-CoV-2 test was positive, but all cultures were negative and infectious markers were low. The baby was discharged after six days and presented again two days later with abdominal distention. He rapidly deteriorated and died on the same day, likely due to sepsis. The repeat SARS-CoV-2 test was negative.

Systemic steroids were given to 20/51 (39·2%) children that were admitted; including 9/11 (81·8%) children in the PICU. Thirteen of 51 (25·5%) children initially received steroids for non-COVID indications, including asthma exacerbation, airway obstruction and leukemia. In 4 of these children the initial indication was a severe pneumonia with hypoxia, steroids were continued in view of subsequent COVID pneumonia diagnosis. In 5/51 (9·8%) children the initial indication for steroids was a COVID pneumonia and they were all younger than 3 months of age. Two children in the oldest age group were given steroids for MIS-C.

A c c e p t e d M a n u s c r i p t 12 In 16/51 (30·8%) hospitalized children a new, incidental, diagnosis was made. Eight children had new cardiovascular diagnoses, including congenital cardiac defects and cardiac arrhythmias. Four were newly diagnosed with tuberculosis, one newly diagnosed acute myeloid leukemia (AML) and two children with clinical rickets confirmed on laboratory assessment. The child with newly diagnosed AML was later also diagnosed with MIS-C after initial chemotherapy, hemophagocytes were confirmed on bone marrow aspiration.

Seven children out of 51 children (13·7%) had an unscheduled re-admission to hospital, including 2 children with worsening of LRTI.

We describe our clinical experiences with COVID-19 in South African children. We found that children under one year of age are disproportionally represented in hospitalization, as 307 of 5168 (6.0%) positive pediatric cases reported in the Western Cape was <1 year of age but almost 50% of the hospitalizations was in this age group (provincial data personal communication, up till end July 2020). These children mainly present with severe respiratory illness requiring significant respiratory support. In contrast, Asia, North America and Europe showed a propensity of infants and young children to have mild symptoms without the need for respiratory support. [2] [3] [4] However, they did report that children less than 1 month of age were at high risk for requiring intensive care admission, especially if viral co-infections were detected. The COVID-19 pandemic in South Africa occurred during the respiratory season, but respiratory viruses were less prevalent during this season due to national lockdown, social distancing and mask wearing. Overall admission numbers were down by one third compared to same period last year (pediatric TBH statistics). The number of children requiring oxygen and NIRS in the young age group in this cohort is important as the need for oxygen A c c e p t e d M a n u s c r i p t 13 may go unrecognized in LMIC, and access to oxygen may be limited resulting in increased mortality. 7,8 Our findings highlight the potential shortcoming and need for wide-spread implementation of oxygen and non-invasive respiratory support strategies throughout Sub-Saharan Africa. We are not able to compare need for oxygen and NIRS in this group to those children with RSV and other common viral LRTI.

In 11 of the 62 hospitalized children a positive SARS-CoV-2 test was positive without the child having symptoms. This is expected as SARS-CoV-2 infection can be seen in asymptomatic individuals. 17 We do not know the proportion of children that have asymptomatic infection as our study was done in a hospital setting and detection of asymptomatic infections are dependent on testing strategy. In some cases it is difficult to rule out causality between SARS-CoV-2 detection. Examples in this study include, cardiac arrhythmia's, focal seizures or stroke. More data is needed in order to understand the full spectrum of SARS-CoV-2 disease in children.

Systemic steroids are commonly given in children presenting with a severe pneumonia with hypoxia as we are concerned about possible Pneumocystis jiroveci pneumonia in our setting. This could potentially have ameliorated the outcomes in especially the youngest children. We did observe that there is a proportion of children that require re-admission to hospital including some presenting with recurrent respiratory symptoms and this will need to be followed up in children. 18, 19 While young children mainly presented with LRTIs, older children had a more varied clinical presentation. There is an increased awareness of gastro-intestinal symptoms 20 associated with a positive SARS-CoV-2 test and potentially MIS-C, which was also seen in our cohort. 21 Over the A c c e p t e d M a n u s c r i p t 14 coming months, Africa will potentially see a relatively high number of MIS-C cases due to our racial demographic, and therefore awareness of this group of conditions is very important. 21 Though the numbers are small, unlike adults 11 , HIV infection, did not seem to contribute to severe COVID-19 illness, but the proportion of children HEU in the admitted children was higher in the youngest children and the antenatal HIV prevalence in the province, which is estimated around 20%. 12, 22 This may indicate that children HEU may be more vulnerable to severe COVID-illness in the In a quarter of the admitted children a new underlying diagnosis was made. This could be partially explained by careful clinical review of each of these cases by an experienced pediatrician. In addition, we speculate that COVID-19 can unmasker underlying illness, as SARS-CoV-2 infection in otherwise well children likely results in mild symptoms or asymptomatic carriage. In addition this should be compared to other viral respiratory tract infections.

The higher CRP and a relative decrease in number of platelets were mostly noted in children over 5 years of age. Higher CRP is linked to higher interleukin-6 levels and more severe disease in adults. 27 Older children might have a more pronounced inflammatory response, which is also seen in adults leading to a different clinical presentation, including MIS-C.

The limitations include the relative small numbers of children and the lack of a control group that presents with other viral respiratory illnesses or concurrent respiratory virus infections, and including the need for oxygen in these different groups. From the children admitted in PICU, 5 out of 6 children with pneumonia had a concurrent respiratory virus detected. Viral co-infections are seen in many respiratory illnesses and the clinical relevance is a point of discussion. 2 data is needed to investigate the role of viral co-infections in children with a positive SARS-CoV-2 test.

Our study shows more severe COVID-19 respiratory illness in especially in the very young children in our setting, which underscores the need for widespread implementation of oxygen and non-invasive respiratory support strategies. The link between COVID-19 and tuberculosis and HIV exposure may need further investigation.

A c c e p t e d M a n u s c r i p t 16

We would like to articulate our gratitude to all colleagues at Department of Paediatrics and Child health involved in the data-collection and management of these children. We would like to thank the data-management team of the Desmond Tutu TB Centre for the support for database development and data-capturing. The data-collection was supported by an unrestricted SEED funding from Stellenbosch University special vice-rector fund for COVID research.

The authors have no conflicts of interest to declare. A c c e p t e d M a n u s c r i p t M a n u s c r i p t * corrected for children able to report these symptoms, older than 3 years * Rashes included 1petechial rash, 2 macular papular rashes, 1erythemateus rash and 2 vesilcular rashes.

A c c e p t e d M a n u s c r i p t 

Epidemiology of COVID-19 Among Children in China

COVID-19 in children and adolescents in Europe: a multinational, multicentre cohort study

Pediatric SARS-CoV-2: Clinical Presentation, Infectivity, and Immune Responses

Early Experience of COVID-19 in a US Children

Risk factors for COVID-19 death in a population cohort study from the Western Cape Province, South Africa

Western Cape Burden of Disease Rapid Review Update

COVID-19 in a child with tuberculous airway compression. Pediatric pulmonology

2019-nCoV) by real-time RT-PCR

Acute appendicitis in MIS-c and COVID-19

Candan SA, Elibol N, Abdullahi A. Consideration of prevention and management of long-term consequences of post-acute respiratory distress syndrome in patients with COVID-19

Serology-positive but minimally symptomatic COVID-19 may still cause lung injury and lung function impairment

Gastrointestinal features in children with COVID-19: an observation of varied presentation in eight children. The Lancet. Child & adolescent health

Multisystem inflammatory syndrome in children in South Africa. The Lancet. Child & adolescent health

HIV-exposed uninfected infants are at increased risk for severe infections in the first year of life

Postinfluenza bacterial pneumonia: host defenses gone awry

Influenza A virus infection impairs mycobacteria-specific T cell responses and mycobacterial clearance in the lung during pulmonary coinfection

Non-specific effects of BCG vaccine on viral infections

Epidemiological and clinical features of 200 hospitalized patients with corona virus disease 2019 outside Wuhan, China: A descriptive study

Comparison of quantitative reverse transcription-PCR to viral culture for assessment of respiratory syncytial virus shedding

Transmission of SARS-CoV-2 in Australian educational settings: a prospective cohort study

SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients

Predicting infectious SARS-CoV-2 from diagnostic samples

A c c e p t e d M a n u s c r i p t